Inhibition protein tyrosine phosphatases by an oxovanadium glutamate complex, Na2[VO(Glu)2(CH3OH)](Glu = glutamate)

BioMetals

Volumn 23, Issue 6, 2010, Pages 1139-1147

  Lu, Liping ^a   Wang, Sulian ^a   Zhu, Miaoli ^a,d   Liu, Zhiwei ^b   Guo, Maolin ^b   Xing, Shu ^c   Fu, Xueqi ^c  

^a SHANXI UNIVERSITY   (China)

^b UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

^c JILIN UNIVERSITY   (China)

^d NANJING UNIVERSITY   (China)

Author keywords

Fluorescence; Inhibition; Oxovanadium glutamate complex; Protein tyrosine phosphatases

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; OXOVANADIUM GLUTAMATE COMPLEX; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPETITIVE INHIBITION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; FLUORESCENCE SPECTROSCOPY; IC 50; INSULIN LIKE ACTIVITY; TITRIMETRY;

COORDINATION COMPLEXES; GLUTAMATES; HUMANS; KINETICS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTEIN TYROSINE PHOSPHATASES; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS; VANADATES;

EID: 78349310735     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-010-9363-8     Document Type: Article

References (47)

1. PJ Alal L Gonneville M Hillman M Becker-Pasha EW Yue B Douty B Wayland P Polam ML Crawley E McLaughlin RB Sparks B Glass A Takvorian AP Combs TC Burn GF Hollis R Wynn 2006 Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B J Biol Chem 281 38013 38021 10.1074/jbc.M607913200 (Pubitemid 46042105)
2. JN Andersen PG Jansen SM Echwald OH Mortensen T Fukada RD Vecchio NK Tonks NPH Møller 2004 A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage FASEB J 18 8 30 1:CAS:528:DC%2BD2cXmtVGmtg%3D%3D 10.1096/fj.02-1212rev 14718383 (Pubitemid 38076462)
3. S Arena S Benvenutis A Bardellia 2005 Genetic analysis of the kinome and phosphatome in cancer Cell Mol Life Sci 62 2092 2099 1:CAS:528: DC%2BD2MXhtFCgtLjK 10.1007/s00018-005-5205-1 16132230 (Pubitemid 41291665)
4. JC Byon AB Kusari J Kusari 1998 Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction Mol Cell Biochem 182 101 108 1:CAS:528:DyaK1cXjtlOns7c%3D 10.1023/A:1006868409841 9609119 (Pubitemid 28181653)
5. Chruscinska EL, Sanna D, Garribba E, Micera G (2008) Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications. Dalton Trans 4903-4916
6. 2+; a potentiometric and spectroscopic study Polyhedron 11 12 1449 1461 1:CAS:528:DyaK38XltF2gurs%3D 10.1016/S0277-5387(00)83138-1
7. DC Crans JJ Smee E Gaidamauskas L Yang 2004 The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds Chem Rev 104 849 902 1:CAS:528:DC%2BD2cXnvFWisw%3D%3D 10.1021/cr020607t 14871144
8. Davis CW (1938) The extent of dissociation of salts in water. part VIII. An equation for the mean ionic activity coefficient of an electrolyte in water, and a revision of the dissociation constants of some sulphates. J Chem Soc 2093-2098
9. F Ding G Zhao J Huang Y Sun L Zhang 2009 Fluorescence spectroscopic investigation of the interaction between chloramphenicol and lysozyme Eur J Med Chem 44 4083 4089 1:CAS:528:DC%2BD1MXptlert7w%3D 10.1016/j.ejmech.2009.04.047 19505746
10. M Elchebly P Payette E Michaliszyn W Cromlish S Collins AL Loy D Normandin A Cheng J Himms-Hagen CC Chan C Ramachandran MJ Gresser ML Tremblay BP Kennedy 1999 Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene Science 283 1544 1548 1:CAS:528:DyaK1MXhs1ymtrs%3D 10.1126/science.283.5407.1544 10066179 (Pubitemid 29133367)
11. Gans P, Sabatini A, Vacca A (1985) SUPERQUAD: an improved general program for computation of formation constants from potentiometric data. J Chem Soc Dalton Trans 1195-1200
12. XL Gao LP Lu ML Zhu CX Yuan JF Ma XQ Fu 2009 Inhibitory activities of some oxovanadium complexes with N-heterocyclic ligands against PTP1B/ALP Acta Chim Sin 67 9 929 936 1:CAS:528:DC%2BD1MXotFamtbc%3D
13. ML Guo BS Yang P Yang 1996 Ethidium bromide as a fluorescent probe for the interaction mode between titanocene dichloride and DNA Chin Sci Bull 41 1098 1103 1:CAS:528:DyaK28XmtlSqtrY%3D
14. Gyurcsik B, Jakusch T, Kiss T (2001) Oxovanadium(IV) complexes of N-D-gluconylamino acids. J Chem Soc Dalton Trans 1053-1057
15. Henry RP, Mitchell PCH, Prue JE (1973) Hydrolysis of oxovanadium(IV) ion and stability of its complexes with 1,2-dihydroxybenzenato(2-) ion. J Chem Soc Dalton Trans 1156-1159
16. CE Heyliger AG Tahiliani JH McNeill 1985 Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats Science 227 1474 1477 1:CAS:528:DyaL2MXhs1Ckur8%3D 10.1126/science.3156405 3156405
17. G Huyer S Liu J Kelly J Moffat P Payette B Kennedy G Tsaprailis MJ Gresser C Ramachandran 1997 Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate J Biol Chem 272 843 851 1:CAS:528:DyaK2sXmtFCmsw%3D%3D 10.1074/jbc.272.2.843 8995372 (Pubitemid 27034572)
18. KA Kenner E Anyanwu JM Olefsky J Kusari 1996 Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signalling J Biol Chem 271 19810 19816 1:CAS:528: DyaK28XltVKrsrg%3D 10.1074/jbc.271.33.19810 8702689 (Pubitemid 26281720)
19. LD Klaman O Boss OD Peroni JK Kim JL Martino LM Zabolotny N Moghal M Lubkin YB Kim AH Sharpe A Stricker-Krongrad GI Shulman BG Neel BB Kahn 2000 Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice Mol Cell Biol 20 5479 5489 1:CAS:528:DC%2BD3cXlt1Sntbs%3D 10.1128/MCB.20.15.5479-5489.2000 10891488 (Pubitemid 30482885)
20. Lide DR (2008) Dissociation constants of organic acids and bases. In: CRC handbook of chemistry and physics, 88th edn. (Internet Version). CRC Press/Taylor and Francis, Boca Raton
21. Lu LP, Gao XL, Wang SX, Liu ZW, Zhu ML, Wu Q, Xing S, Fu XQ, Guo ML. Inhibition of protein tyrosine phosphatases by vanadyl-biguanide complexes. Eur J Med Chem (submitted)
22. R Maccari P Paoli R Ottana M Jacomelli R Ciurleo G Manao T Steindl T Langer MG Vigorita G Camici 2007 5-Arylidene-2, 4-thiazolidinediones as inhibitors of protein tyrosine phosphatases Bioorg Med Chem 15 5137 5149 1:CAS:528:DC%2BD2sXmtlahtrs%3D 10.1016/j.bmc.2007.05.027 17543532 (Pubitemid 46880378)
23. APD Marques ER Dockal FC Skrobot ILV Rosa 2007 Synthesis, characterization and catalytic study of [N, N'-bis(3-ethoxysalicylidene)-m- xylylenediamine] oxovanadium(IV) complex Inorg Chem Commun 10 255 261 1:CAS:528:DC%2BD2sXhvVGmtbY%3D 10.1016/j.inoche.2006.10.025
24. JH McNeill VG Yuen S Dai C Orvig 1995 Increased potency of vanadium using organic ligands Mol Cell Biochem 153 175 180 1:CAS:528:DyaK28Xis1yntQ%3D%3D 10.1007/BF01075935 8927036 (Pubitemid 26003382)
25. S Mondal SP Rath KK Rajak A Chakravorty 1998 A family of (N-salicylidene-α-amino acidato) vanadate esters incorporating chelated propane-1, 3-diol and glycerol: synthesis, structure, and reaction Inorg Chem 37 8 1713 1719 1:CAS:528:DyaK1cXitVyrsLk%3D 10.1021/ic971277b
26. Mukherjee R, Donnay EG, Radomski MA, Miller C, Redfern DA, Gericke A, Damron DS, Brasch NE (2008) Vanadium-vitamin B12 bioconjugates as potential therapeutics for treating diabetes. Chem Commun 3783-3785
27. M Na L Cui BS Min KH Bae JK Yoo BY Kim WK Oh JS Ahn 2006 Protein tyrosine phosphatase 1B inhibitory activity of triterpenes isolated from Astilbe Koreana Bioorg Med Chem Lett 16 3273 3276 1:CAS:528:DC%2BD28XksFeqs7s%3D 10.1016/j.bmcl.2006.03.036 16580200
28. F Nxumalo NR Glover AS Tracey 1998 Reactions of vanadium(V) complexes of N, N-dimethylhydroxylamine with sulfur-containing ligands: implications for protein tyrosine phosphatase inhibition J Biol Inorg Chem 3 534 542 1:CAS:528:DyaK1cXnvFOqu7g%3D 10.1007/s007750050265 (Pubitemid 28478113)
29. RN Patel VK Soni S Sharma KK Shukla KB Pandeya 2003 pH-metric and spectrophotometric study of oxovanadium(IV) with aspartic acid, glutamic acid and imidazoles Oxid Commun 26 358 367 1:CAS:528:DC%2BD3sXosVKiu7s%3D
30. 4) as the active component J Inorg Biochem 96 321 330 1:CAS:528:DC%2BD3sXlvVSlsLw%3D 10.1016/S0162-0134(03)00236-8 12888267 (Pubitemid 36900369)
31. BI Posner R Faure JW Burgess AP Bevan D Lachance G Zhang-Sun IG Fantus JB Ng DA Hall BS Lum 1994 Peroxovanadium compounds J Biol Chem 269 4596 4604 1:CAS:528:DyaK2cXis1Smsbk%3D 8308031
32. YA Puius Y Zhao M Sullivan DS Lawrence SC Almo ZY Zhang 1997 Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design Proc Natl Acad Sci USA 94 13420 13425 1:CAS:528:DyaK2sXotVamtbs%3D 10.1073/pnas.94.25.13420 9391040 (Pubitemid 28009597)
33. PD Ross S Subramanian 1981 Thermodynamics of protein association reactions: forces contributing to stability Biochemistry 20 3096 3102 1:CAS:528:DyaL3MXktF2qsb0%3D 10.1021/bi00514a017 7248271
34. AR Saltiel R Kahn 2001 Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 799 806 1:CAS:528:DC%2BD38Xhtlylsg%3D%3D 10.1038/414799a 11742412 (Pubitemid 34000783)
35. A Salmeen JN Andersen MP Myers NK Tonks D Barford 2000 Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B Mol Cell 6 1401 1412 1:CAS:528: DC%2BD3MXlvFagsw%3D%3D 10.1016/S1097-2765(00)00137-4 11163213 (Pubitemid 32045932)
36. SDBS Nos 4736, 4628, and 1097; SDBSWeb: http://riodb01.ibase.aist.go.jp/ sdbs/ (National Institute of Advanced Industrial Science and Technology, Accessed 9 Jan 2010)
37. S Shrestha BRK Bhattarai H Lee H Cho 2007 Mono- and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs Bioorg Med Chem 15 6535 6548 1:CAS:528:DC%2BD2sXpsFKktLk%3D 10.1016/j.bmc.2007.07.010 17692525 (Pubitemid 47302313)
38. RB Sparks P Polam W Zhu ML Crawley A Takvorian E McLaughlin M Wei PJ Ala L Gonneville N Taylor Y Li R Wynn TC Burn PCC Liu AP Combs 2007 Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors Bioorg Med Chem Lett 17 736 740 1:CAS:528: DC%2BD2sXotFamsw%3D%3D 10.1016/j.bmcl.2006.10.079 17097290 (Pubitemid 46127637)
39. HY Wang M Zhang QL Lv NN Yue B Gong 2009 Determination of berberine and the study of fluorescence quenching mechanism between berberine and enzyme-catalyzed product Spectrochim Acta Part A 73 682 686 10.1016/j.saa.2009. 03.017
40. QM Wang LP Lu CX Yuan K Pei ZW Liu ML Guo ML Zhu 2010 Potent inhibition of protein tyrosine phosphatase 1B by copper complexes: implication to copper toxicity in biological systems Chem Commun 46 3547 3549 1:CAS:528: DC%2BC3cXlvVSkurc%3D 10.1039/b925603b
41. CL Winter JS Lange MG Davis GS Gerwe TR Downs KG Peters B Kasibhatla 2005 A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato) oxovanadium(IV), improves glucose tolerance and prevents diabetes in zucker diabetic fatty rats Exp Biol Med 230 207 216 1:CAS:528:DC%2BD2MXhvFKmsL8%3D
42. J Xie CT Seto 2007 A two stage click-based library of protein tyrosine phosphatase inhibitors Bioorg Med Chem 15 458 473 1:CAS:528:DC%2BD28Xht1Cmt7%2FJ 10.1016/j.bmc.2006.09.036 17046267 (Pubitemid 44738556)
43. CX Yuan LP Lu XL Gao YB Wu JJ Yue ML Guo Y Li XQ Fu ML Zhu 2009 Ternary oxovanadium(IV) complexes of ono-donor schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities J Biol Inorg Chem 14 841 851 1:CAS:528: DC%2BD1MXjt1Sqs7c%3D 10.1007/s00775-009-0496-6 19290551
44. Yuan CX, Lu LP, Wu YB, Liu ZW, Guo ML, Xing S, Fu XQ, Zhu ML (2010) Synthesis, characterization, and protein tyrosine phosphatases inhibition activities of oxovanadium(IV) complexes with schiff base and polypyridyl derivatives. J Inorg Biochem doi: 10.1016/j.jinorgbio.2010.05.003
45. JR Zamian ER Dockal G Castellano G Oliva 1995 Synthesis and characterization of [N, N'-ethylenebis(3- ethoxysalicylideneaminato)] oxovanadium(IV) Polyhedron 14 2411 2418 1:CAS:528:DyaK2MXotVWitrg%3D 10.1016/0277-5387(95)00071-Y
46. ZY Zhang 2001 Protein tyrosine phosphatases: prospects for therapeutics Curr Opin Chem Biol 5 416 423 1:CAS:528:DC%2BD3MXltlyqsLs%3D 10.1016/S1367-5931(00)00223-4 11470605 (Pubitemid 32900514)
47. BA Zinker CM Rondinone JM Trevillyan RJ Gum JE Clampit JF Waring N Xie D Wilcox P Jacobson L Frost PE Kroeger RM Reilly S Koterski TJ Opgenorth RG Ulrich S Crosby M Butler SF Murray RA McKay S Bhanot BP Monia MR Jirousek 2002 PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice Proc Natl Acad Sci USA 99 11357 11362 1:CAS:528:DC%2BD38XmslSmurc%3D 10.1073/pnas.142298199 12169659 (Pubitemid 34920930)